Bionik Ships 250th Robotic Therapy System

Biotech Investing

Bionik Laboratories announced a key cornerstone by shipping the 250th interactive robotic therapy system.

Bionik Laboratories (OTCQX:BNKL) announced a key cornerstone by shipping the 250th interactive robotic therapy system.
As quoted in the press release:

Bionik’s robotic solutions are currently providing effective and affordable patient care with respect to treatment of neurological disorders in 20 countries and in over 200 hospitals. Bionik has seven robotic products, of which three are FDA-cleared and in the market globally, and four products that are in various stages of development. Its InMotion ARM, InMotion HAND, and InMotion WRIST interactive robotic therapy systems sense a patient’s movement and respond to a patient’s continually-changing ability, all in real time.
“We are excited to reach this milestone as a company and to bring our robotic systems into medical facilities to provide innovative rehabilitation solutions for patients across the country,” said Michal Prywata, co-founder, chief technology officer and director of Bionik Laboratories. “Neurological disorders afflict millions of people each year, but current physical therapy methods are simply too limited to help patients regain the mobility they have lost. We believe our robotic systems offer the best in patient care and our continued penetration into the market showcases that.”

Click here to read the full press release.

Source: www.newswire.ca

The Conversation (0)
×